BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16546547)

  • 1. Progress and hindrances in tuberculosis vaccine development.
    Doherty TM; Rook G
    Lancet; 2006 Mar; 367(9514):947-9. PubMed ID: 16546547
    [No Abstract]   [Full Text] [Related]  

  • 2. The Helper T Cell's Dilemma in Tuberculosis.
    Barber DL
    Cell Host Microbe; 2017 Jun; 21(6):655-656. PubMed ID: 28618262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advance in DNA vaccine against Mycobacterium tuberculosis].
    Wang BL; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398
    [No Abstract]   [Full Text] [Related]  

  • 4. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST; Kaufmann SH
    Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to tuberculosis in developing countries: implications for new vaccines.
    Rook GA; Dheda K; Zumla A
    Nat Rev Immunol; 2005 Aug; 5(8):661-7. PubMed ID: 16056257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis: vaccine and drug development.
    Mitsuyama M; McMurray DN
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S10-3. PubMed ID: 17616481
    [No Abstract]   [Full Text] [Related]  

  • 9. Research progress in the field of immunotherapeutic vaccination in human TB and the way ahead.
    Méndez-Samperio P
    Immunotherapy; 2016 Sep; 8(9):987-9. PubMed ID: 27485072
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
    Giri PK; Verma I; Khuller GK
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):233-41. PubMed ID: 16831210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis vaccines: Rising opportunities.
    Vekemans J; O'Brien KL; Farrar J
    PLoS Med; 2019 Apr; 16(4):e1002791. PubMed ID: 31013268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in understanding the human immune responses to Mycobacterium tuberculosis.
    Barnes PF; Samten B; Shams H; Vankayalapatib R
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S5-9. PubMed ID: 20006306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New multistage TB vaccine shown to produce stronger, longer-lasting response against Mycobacterium tuberculosis.
    Immunotherapy; 2011 Mar; 3(3):309. PubMed ID: 21395372
    [No Abstract]   [Full Text] [Related]  

  • 16. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH
    Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of tuberculosis vaccine trials under financial constraints.
    García-Basteiro AL; Ruhwald M; Lange C
    Expert Rev Vaccines; 2016 Jul; 15(7):799-801. PubMed ID: 27078056
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for a novel vaccine against tuberculosis.
    Dietrich J; Weldingh K; Andersen P
    Vet Microbiol; 2006 Feb; 112(2-4):163-9. PubMed ID: 16325357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent findings in immunology give tuberculosis vaccines a new boost.
    Kaufmann SH
    Trends Immunol; 2005 Dec; 26(12):660-7. PubMed ID: 16246622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.